304946199	304946199	CD	B-NP	O
|	|	NN	I-NP	O
BMC	BMC	NN	I-NP	O
|	|	NN	I-NP	O
47548866	47548866	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7576393	7576393	CD	B-NP	O
|	|	CC	I-NP	O
7/12/2005	7/12/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHRONIC	CHRONIC	NNP	I-NP	I-protein
OBSTRUCTIVE	OBSTRUCTIVE	NNP	I-NP	I-protein
PULMONARY	PULMONARY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/9/2005	3/9/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/21/2005	1/21/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
REOPELL	REOPELL	NNP	B-NP	O
,	,	,	O	O
ROLF	ROLF	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
causing	cause	VBG	B-VP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
is	be	VBZ	B-VP	O
sinus	sinus	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
with	with	IN	B-PP	O
apnea	apnea	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
71-year-old	71-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
nonischemic	nonischemic	JJ	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
prior	prior	JJ	B-NP	O
admission	admission	NN	I-NP	O
indicating	indicate	VBG	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
ablation	ablation	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
5/24/05	5/24/05	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
witnessed	witness	VBN	I-NP	O
apneic	apneic	JJ	I-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
having	have	VBG	B-VP	O
stopped	stop	VBD	I-VP	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
frustration	frustration	NN	I-NP	O
with	with	IN	B-PP	O
incontinence	incontinence	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
then	then	RB	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
upon	upon	IN	B-PP	O
walking	walk	VBG	B-VP	O
10	10	CD	B-NP	O
feet	foot	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Centsshealt	Centsshealt	NNP	I-NP	O
Careman	Careman	NNP	I-NP	O
Inerist	Inerist	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
saturating	saturate	VBG	I-VP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
nonrebreather	nonrebreather	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ABG	ABG	NNP	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
7.31	7.31	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
PCO2	PCO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
;	;	:	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
tried	try	VBN	I-VP	O
on	on	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
without	without	IN	B-PP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
either	either	CC	O	O
PCO2	PCO2	NN	B-NP	B-protein
or	or	CC	I-NP	O
PO2	PO2	NN	I-NP	B-protein
.	.	.	O	O

While	While	IN	B-SBAR	O
being	be	VBG	B-VP	O
interviewed	interview	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
residents	resident	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
30-second	30-second	JJ	I-NP	O
apneic	apneic	JJ	I-NP	O
episode	episode	NN	I-NP	O
with	with	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
and	and	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
;	;	:	O	O
his	his	PRP$	B-NP	O
sensorium	sensorium	NN	I-NP	O
quickly	quickly	RB	B-VP	O
returned	return	VBD	I-VP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
retained	retain	VBD	B-VP	O
no	no	DT	B-NP	O
memory	memory	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
DuoNebs	DuoNeb	NNS	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
CHF/apnea/sinus	CHF/apnea/sinus	NN	B-NP	O
arrest	arrest	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
floor	floor	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
nonischemic	nonischemic	JJ	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
2/13	2/13	CD	B-NP	O
echo	echo	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
global	global	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
;	;	:	O	O
7/18	7/18	CD	B-NP	O
echo	echo	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
hypokinesis	hypokinesis	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
ablation	ablation	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
2003	2003	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hyperostosis	Hyperostosis	NN	B-NP	O
frontalis	frontalis	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Complex	Complex	JJ	B-NP	O
renal	renal	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
versus	versus	IN	B-PP	O
angiomyolipoma	angiomyolipoma	NN	B-NP	O
,	,	,	O	O
resected	resecte	VBN	B-VP	O
via	via	IN	B-PP	O
laparoscopy	laparoscopy	NN	B-NP	O
in	in	IN	B-PP	O
8/2	8/2	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Morbid	Morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
with	with	IN	B-PP	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Allopurinol	Allopurinol	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Iron	Iron	NNP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
discontinued	discontinue	VBN	B-VP	O
on	on	IN	B-PP	O
11/28/05	11/28/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	B-protein
inhaler	inhaler	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Flomax	Flomax	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Hytrin	Hytrin	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
at	at	IN	B-PP	O
Rys	Rys	NNP	B-NP	O
Ville	Ville	NNP	I-NP	O
Santster	Santster	NNP	I-NP	O
He	He	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retire	VBN	I-NP	O
Burg	Burg	NNP	I-NP	O
Bovalle	Bovalle	NNP	I-NP	O
Ge	Ge	NNP	I-NP	O
employee	employee	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
ex-smoker	ex-smoker	NN	I-NP	O
,	,	,	O	O
quit	quit	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1960s	1960	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
drinker	drinker	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
20s	20	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
now	now	RB	B-ADVP	O
he	he	PRP	B-NP	O
rarely	rarely	RB	B-ADVP	O
drinks	drink	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Gastric	Gastric	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
father	father	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
53	53	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
125/65	125/65	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
saturating	saturate	VBG	B-VP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
by	by	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	I-ADJP	O
alert	alert	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
are	be	VBP	B-VP	O
equally	equally	RB	B-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	JJ	B-ADJP	O
,	,	,	O	O
sclerae	sclerae	NNS	B-NP	O
are	be	VBP	B-VP	O
anicteric	anicteric	JJ	B-NP	O
,	,	,	I-NP	O
moist	moist	JJ	I-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
JVP	JVP	NN	B-NP	B-protein
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

Lung	Lung	NN	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
or	or	CC	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
and	and	CC	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.3	2.3	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
of	of	IN	B-PP	O
500	500	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
admission	admission	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
Sinus	Sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
40s	40	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

SUMMARY	SUMMARY	NN	B-NP	O
OF	OF	IN	B-PP	O
THE	THE	DT	B-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
ISSUE	ISSUE	NNP	I-NP	O
:	:	:	O	O
Assessment	Assessment	NN	B-NP	O
and	and	CC	I-NP	O
Plan	Plan	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
71-year-old	71-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
nonischemic	nonischemic	JJ	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
preserved	preserve	VBN	I-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
arrest	arrest	NN	I-NP	O
,	,	,	O	O
ultimately	ultimately	RB	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
nonischemic	nonischemic	JJ	I-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
preserved	preserve	VBN	I-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	CC	O	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
without	without	IN	B-PP	O
hypokinesis	hypokinesis	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
prior	prior	JJ	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	B-protein
left	left	JJ	I-NP	I-protein
ventricular	ventricular	JJ	I-NP	I-protein
hypokinesis	hypokinesis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
signs	sign	NNS	B-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
having	have	VBG	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
for	for	IN	B-PP	O
about	about	RB	B-NP	O
a	a	DT	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
,	,	,	O	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
10	10	CD	I-NP	O
kg	kg	NN	I-NP	O
since	since	IN	B-PP	O
admission	admission	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-ADVP	O
including	include	VBG	B-PP	O
diuresis	diuresis	NN	B-NP	O
with	with	IN	B-PP	O
ultrafiltration	ultrafiltration	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Following	Follow	VBG	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Lasix	Lasix	NN	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
down	down	RB	B-ADVP	O
gradually	gradually	RB	B-ADVP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
cautioned	caution	VBD	B-VP	O
with	with	IN	B-PP	O
administration	administration	NN	B-NP	O
giving	give	VBG	B-VP	O
a	a	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
captopril	captopril	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
up	up	RB	I-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
held	hold	VBN	B-VP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
metoprolol	metoprolol	NN	B-NP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Electrophysiology	Electrophysiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
sinus	sinus	NN	B-NP	O
arrest	arrest	NN	I-NP	O
of	of	IN	B-PP	O
8-9	8-9	CD	B-NP	O
seconds	second	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
apnea	apnea	NN	B-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
sinus	sinus	NN	B-NP	O
arrest	arrest	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
seconds	second	NNS	I-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
apnea	apnea	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
last	last	JJ	I-NP	O
such	such	JJ	I-NP	O
episode	episode	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
8/16/05	8/16/05	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation/flutter	fibrillation/flutter	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
ablation	ablation	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/30/05	4/30/05	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
pacemaker	pacemaker	NN	B-NP	O
placement	placement	NN	I-NP	O
through	through	IN	B-PP	O
cephalic	cephalic	JJ	B-NP	O
veins	vein	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
apnea	apnea	NN	B-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
sinus	sinus	NN	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
apnea	apnea	NN	I-NP	O
episodes	episode	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
for	for	IN	B-PP	O
formal	formal	JJ	B-NP	O
sleep	sleep	JJ	I-NP	O
study	study	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
roughly	roughly	RB	B-ADVP	O
around	around	IN	B-PP	O
baseline	baseline	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
rose	rise	VBD	B-VP	O
briskly	briskly	RB	B-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
3.2	3.2	CD	B-NP	O
on	on	IN	B-PP	O
4/30/05	4/30/05	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
FENa	FENa	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
6-8	6-8	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
FENa	FENa	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
3.2	3.2	CD	B-NP	O
and	and	CC	O	O
following	follow	VBG	B-NP	O
10	10	CD	B-NP	O
kg	kg	NN	I-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
1.86	1.86	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-cell_type
urine	urine	NN	I-NP	I-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
UA	UA	NN	I-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
UTI	UTI	NN	I-NP	B-cell_line
plus	plus	CC	O	I-cell_line
triple	triple	JJ	B-NP	I-cell_line
phosphate	phosphate	NN	I-NP	I-cell_line
crystals	crystal	NNS	I-NP	I-cell_line
;	;	:	O	I-cell_line
urine	urine	NN	B-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
showed	show	VBD	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
colonies	colony	NNS	I-NP	O
of	of	IN	B-PP	O
mixed	mix	VBN	B-NP	O
morphology	morphology	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
intravascular	intravascular	JJ	B-NP	O
depletion	depletion	NN	I-NP	O
and	and	CC	O	O
possibly	possibly	RB	B-ADVP	O
UTI	UTI	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
to	to	TO	I-VP	O
cover	cover	VB	I-VP	O
GU	GU	NN	B-NP	O
microbial	microbial	JJ	I-NP	O
flora	flora	NN	I-NP	O
and	and	CC	I-NP	O
SNHU	SNHU	NN	I-NP	O
microbes	microbe	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Regular	Regular	JJ	I-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
expected	expect	VBN	I-VP	O
to	to	TO	B-PP	O
having	have	VBG	B-VP	O
an	an	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
cefazolin	cefazolin	NN	B-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
stay	stay	VB	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
for	for	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Captopril	Captopril	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Ferrous	Ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneous	subcutaneous	JJ	B-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
Insulin	Insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
subcutaneous	subcutaneous	JJ	I-NP	I-protein
q.a.c.	q.a.c.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Keflex	Keflex	NNP	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
x12	x12	NN	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
3/25/05	3/25/05	CD	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-8113387	1-8113387	CD	B-NP	O
EMSFocus	EMSFocus	NN	I-NP	O
transcriptionists	transcriptionist	NNS	I-NP	O
Dictated	Dictate	VBD	B-VP	O
By	By	NNP	B-NP	O
:	:	:	O	O
DUBIEL	DUBIEL	NNP	B-NP	O
,	,	,	O	O
SCOT	SCOT	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MCGARITY	MCGARITY	NNP	B-NP	O
,	,	,	O	O
LINCOLN	LINCOLN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7303323	7303323	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/25/05	3/25/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/25/05	3/25/05	CD	B-NP	O

